XRSM:XETRA:XETRA-Xtrackers MSCI USA ESG Screened UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 45.315

Change

-0.37 (-0.80)%

Market Cap

N/A

Volume

130.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.57 (-1.24%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.58 (-0.57%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.28 (-1.19%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.15 (-1.12%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.06 (-1.19%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.33 (-1.39%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.09 (-0.72%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.35 (+0.63%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.04 (+0.37%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.04 (+0.03%)

USD 12.26B

ETFs Containing XRSM:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.86% 18% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.86% 23% F 23% F
Trailing 12 Months  
Capital Gain 9.66% 81% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.66% 81% B- 77% C+
Trailing 5 Years  
Capital Gain 117.08% 94% A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 117.08% 94% A 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 17.09% 89% A- 87% B+
Dividend Return 17.09% 89% A- 86% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.69% 26% F 39% F
Risk Adjusted Return 102.42% 90% A- 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.